Maternal Hybrid Immunity and Risk of Infant COVID-19 Hospitalizations: National Case-Control Study in Israel
(Abstracted from Nat Commun 2024;15:2846) Infants with COVID-19, especially the Omicron variant, are at increased risk of acute respiratory failure and hospitalization. Pfizer and Moderna mRNA vaccines significantly reduce this risk but are not approved for infants under 6 months.
Authors
- Eli Melul
- Ofer Beharier (ORCID: https://orcid.org/0000-0001-5317-4512)
- Michal Lipschuetz (ORCID: https://orcid.org/0000-0002-7370-0417)
- Yishai Sompolinsky
- Simcha Yagel (ORCID: https://orcid.org/0000-0002-1412-5862)
- Adva Cahen‐Peretz (ORCID: https://orcid.org/0000-0002-3489-6330)
- Joshua Guedalia (ORCID: https://orcid.org/0000-0002-3458-7896)
- Galit Shefer
- Ronit Calderon‐Margalit (ORCID: https://orcid.org/0000-0002-3369-2758)
- Zivanit Ergaz‐Shaltiel
- S. M. Cohen (ORCID: https://orcid.org/0000-0001-6359-3729)
- Debra Goldman-Whol
Institutions
- RSPC MT (BY)
- Hi-Z Technology (United States) (US)
Publication Details
- Journal
- Obstetrical & Gynecological Survey
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1097/ogx.0000000000001337
- Citations
- 2
- Primary Topic
- Vaccine Coverage and Hesitancy
- Type
- article
- Field-Weighted Citation Impact
- 1.06